Hydrocortisone/Neomycin/Polymyxin B Ophthalmic Suspension Rx
Generic Name and Formulations:
Hydrocortisone 10mg, Neomycin (as sulfate) 3.5mg, polymyxin B sulfate 10000 Units; per mL; contains thimersol.
Various generic manufacturers
Indications for Hydrocortisone/Neomycin/Polymyxin B Ophthalmic Suspension:
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
1 or 2 drops in affected eye(s) every 3 or 4 hours, depending on severity. Max initial ℞: 20mL; do not refill without further evaluation.
Ocular fungal, viral or mycobacterial infections.
Do not inject into the eye. Corneal or scleral thinning. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antibiotics + steroid.
Local irritation, sensitization (itching, swelling, conjunctival erythema), masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.
Formerly known under the brand name Cortisporin Ophthalmic.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL